New York, December 17, 2025 — Medline Inc., the largest provider of medical-surgical products and supply chain solutions serving all points of care, officially entered the public markets today as executives, employees, customers, and partners gathered at the Nasdaq MarketSite in Times Square to commemorate the company’s Initial Public Offering and first day of trading under the ticker Nasdaq: MDLN. The ceremonial ringing of the Opening Bell, held between 9:15 a.m. and 9:45 a.m. ET, symbolized a milestone moment in Medline’s decades-long evolution from a family-owned healthcare supplier into a publicly traded global healthcare leader.
The event brought together Medline’s senior leadership team, representatives from Nasdaq, and invited guests from across the healthcare ecosystem. Against the backdrop of Times Square’s iconic digital displays, Medline’s leadership reflected on the company’s history, mission, and future as a public company committed to advancing patient care through innovation, scale, and operational excellence.
A Milestone Moment for Medline
Founded more than half a century ago, Medline has grown into the largest privately held manufacturer and distributor of medical-surgical supplies in the United States, serving hospitals, physician offices, surgery centers, long-term care facilities, and home health providers. The company’s decision to go public marks a pivotal step in its strategic journey, providing access to additional capital to accelerate growth, invest in innovation, and expand its global footprint.
Standing on the Nasdaq stage, Medline executives emphasized that the IPO is not a departure from the company’s core values, but rather an extension of its long-standing commitment to customers and patients. “Today is about honoring our past while investing in our future,” said a senior Medline executive during remarks at the ceremony. “Ringing the Opening Bell represents the trust our customers place in us, the dedication of our employees, and our belief that Medline can play an even greater role in strengthening healthcare systems around the world.”
The bell-ringing ceremony, a hallmark of Nasdaq’s public market tradition, was broadcast live from the MarketSite and displayed across Times Square’s towering screens. Medline employees from across the organization watched remotely, many gathering in offices and distribution centers nationwide to celebrate the moment together.
From Family Enterprise to Public Company
Medline’s roots trace back to a family-founded enterprise built on relationships, reliability, and service. Over the years, the company expanded its product portfolio to include thousands of medical-surgical items, proprietary brands, and value-added supply chain solutions designed to reduce costs and improve efficiency for healthcare providers.
Industry analysts have long cited Medline’s vertically integrated model as a differentiator, combining manufacturing, distribution, and logistics capabilities at scale. This approach has enabled the company to respond quickly to customer needs, manage complex supply chains, and maintain continuity of care during periods of disruption.
The transition to a publicly traded company represents a new phase in this evolution. While Medline has operated with the scale and sophistication of a public enterprise for years, the IPO introduces a broader investor base and increased transparency. Company leaders have stressed that Medline’s culture—anchored in long-term thinking and customer focus—will remain central as it navigates life in the public markets.
Nasdaq Partnership and Market Debut
Nasdaq officials welcomed Medline to the exchange, highlighting the company’s role in supporting healthcare delivery across the United States and internationally. “Medline’s debut on Nasdaq underscores the strength and resilience of companies driving innovation in healthcare,” said a Nasdaq representative at the event. “We are proud to host Medline as it begins this next chapter as a public company.”
As trading commenced, MDLN shares began changing hands, marking the company’s formal entry into the public markets. Investors closely watched the debut, viewing Medline as a bellwether for the healthcare supply chain sector and a company positioned to benefit from long-term trends such as an aging population, increased demand for care, and the ongoing modernization of healthcare infrastructure.
Market observers noted that Medline’s scale, diversified customer base, and essential role in healthcare delivery have made it a closely followed name among institutional investors. The IPO also reflects broader interest in companies that provide the operational backbone of healthcare, often operating behind the scenes but critical to patient outcomes.
Investing in Innovation and Resilience
In statements surrounding the IPO, Medline outlined its strategic priorities for the years ahead. These include continued investment in product innovation, expansion of distribution and logistics capabilities, and the use of data and technology to enhance supply chain visibility and efficiency for customers.
The company has also emphasized resilience as a core focus, informed by lessons learned during recent global supply chain disruptions. By strengthening domestic manufacturing, diversifying sourcing, and leveraging advanced analytics, Medline aims to help healthcare providers navigate uncertainty while maintaining high standards of care.
Environmental, social, and governance (ESG) considerations are also expected to play an increasingly prominent role in Medline’s public company strategy. Leadership has pointed to ongoing initiatives to reduce waste, improve energy efficiency across facilities, and support workforce development within the communities the company serves.
Employees at the Center of the Celebration
While the Nasdaq ceremony was brief, its significance resonated deeply across Medline’s workforce. Employees—often referred to internally as “Medline teammates”—are widely regarded as the backbone of the company’s success, from manufacturing floors and warehouses to sales teams and corporate offices.
Many employees shared messages of pride and excitement on internal channels as the Opening Bell rang. For long-tenured team members, the IPO represented recognition of years of hard work and dedication. For newer employees, it symbolized opportunity and the chance to help shape the future of a publicly traded healthcare leader.
Medline executives have reiterated that employee engagement and development will remain priorities, even as the company adapts to the demands of public market reporting and investor relations. “Our people are the reason we’re here today,” one executive noted. “Becoming a public company doesn’t change that—it reinforces it.”
Implications for the Healthcare Industry
Medline’s IPO and Nasdaq debut arrive at a time of significant transformation within the healthcare industry. Providers are under pressure to deliver higher-quality care at lower cost, while navigating labor shortages, regulatory complexity, and evolving patient expectations.
As a major supplier and logistics partner, Medline plays a critical role in helping healthcare organisations meet these challenges. Its ability to deliver reliable access to essential products—from gloves and gowns to advanced surgical supplies—directly impacts clinical operations and patient safety.
Industry experts suggest that Medline’s public listing could further elevate the profile of the healthcare supply chain sector, drawing attention to the importance of logistics, inventory management, and manufacturing in delivering care. Increased visibility may also drive innovation and competition, benefiting providers and patients alike.
Looking Ahead
As the Opening Bell concluded and the screens of Times Square shifted to the day’s market activity, Medline’s leadership team left the Nasdaq MarketSite with a sense of momentum and responsibility. The IPO marks not an endpoint, but a beginning—one that carries new expectations from investors, customers, and the broader healthcare community.
In the months and years ahead, Medline will be measured not only by financial performance, but by its ability to uphold its mission of improving healthcare outcomes through dependable products and solutions. Company leaders have expressed confidence that Medline’s scale, culture, and experience position it well for the road ahead.
For now, the ringing of the Opening Bell stands as a defining moment in Medline’s story—a public affirmation of a company built to serve healthcare providers at every point of care, now stepping onto the global stage as a publicly traded enterprise.
As trading in MDLN continues, today’s ceremony will be remembered as the moment Medline formally joined the ranks of Nasdaq-listed companies, carrying with it a legacy of service and a vision for the future of healthcare supply chain excellence.